Earnings, adjusted for non-recurring costs and amortization costs, came to $1.13 per share. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.07 per share. AbbVie expects full-year earnings in the range of $4.26 to $4.28 per share.